Siasun Robot&Automation Company's IPO on the GEM has been questioned. It has already mastered core technologies such as whole-body motion control algorithms.

On May 26th, Leju Intelligent (Shenzhen) Co., Ltd. (referred to as Leju Intelligent) applied for a change in the status of its application for listing on the Shenzhen Stock Exchange's Growth Enterprise Board to "under inquiry". Orient is its sponsor institution, and it plans to raise 2.6 billion yuan. According to the prospectus, the company is a global leading intelligent technology enterprise specializing in the research, development, production, and sales of humanoid Siasun Robot & Automation. The company focuses on the full-stack technology research and development of humanoid Siasun Robot & Automation "brain - small brain - body", as well as providing application solutions. The company has mastered core technologies in the field of humanoid Siasun Robot & Automation such as full-body motion control algorithms, high-performance integrated joint design, and related intelligent humanoid technologies. The company has been recognized with multiple authoritative certifications such as being a national-level specialized and new "little giant" enterprise, the "Guangdong Province High Dynamic Biped Siasun Robot & Automation Engineering Technology Research Center", "Forbes China Artificial Intelligence Technology Enterprise 2025", and "Leading Enterprise in China's Intelligent Siasun Robot & Automation 2025". The company has participated in numerous national and provincial scientific research projects, with projects winning awards such as the second prize of the highest award in China's artificial intelligence field- the "Wu Wenjun Artificial Intelligence Science and Technology Award" for technological progress and the "XAIR Award" for outstanding artificial intelligence and Siasun Robot & Automation in Guangdong Province. The Chairman of the Board of the company, Leng Xiaokun, serves as a member of the National Ministry of Industry and Information Technology's humanoid Siasun Robot & Automation Standardization Technical Committee and as the Chairman of the Work Committee of the OpenLET Intelligent Open Source Dataset Community of the Open Atomic Foundation. As of December 31, 2025, the company had a total of 175 authorized patents, including 85 invention patents, continuously driving the technological development and industrial breakthroughs of humanoid Siasun Robot & Automation. The company's main business is the research, production, and sales of humanoid Siasun Robot & Automation. The main products are humanoid Siasun Robot & Automation, currently covering a full range of sizes and models, mainly including the Kuavo series, Roban series, and Aelos series. In addition to humanoid Siasun Robot & Automation, the company also has other intelligent products for programming education and medical services. The Kuavo series is a key research and development product of the company, representing the core strategic products of the company in the field of artificial intelligence and intelligent humanoid. It has started to be used in various scenarios such as scientific research education, commercial services, data collection, and industrial manufacturing. The Roban series is a key development and teaching platform for small and medium-sized humanoid Siasun Robot & Automation created by the company. It is a key product launched by the company for research and education in the field of artificial intelligence and intelligent humanoid, and has achieved large-scale application in research and training education scenarios. The Aelos series is a small humanoid Siasun Robot & Automation product launched by the company for the popularization of artificial intelligence basic education. It is the cornerstone product of the company's AI education product series covering different levels of primary, middle, vocational, and university education needs for artificial intelligence programming. Among other intelligent products, the Cube and Pando are intelligent products launched by the company for children's artificial intelligence enlightenment education. Together with the Roban series and Aelos series, they form a complete lineup of the company's artificial intelligence education products to meet the needs of AI teaching at all educational levels. Fluvo is a product the company is exploring for application in medical scenarios. Financially, in the financial years of 2023, 2024, and 2025, the company achieved operating incomes of approximately 53.98 million yuan, 55.50 million yuan, and 258 million yuan respectively; during the same periods, net profits were -41.1161 million yuan, -60.1287 million yuan, and -71.2458 million yuan respectively.